STM | ||
---|---|---|
OUTLOOK RATING 1..100 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | |
PROFIT vs RISK RATING 1..100 | 87 | |
SMR RATING 1..100 | 80 | |
PRICE GROWTH RATING 1..100 | 41 | |
P/E GROWTH RATING 1..100 | 6 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STM | |
---|---|
RSI ODDS (%) | 1 day ago81% |
Stochastic ODDS (%) | 1 day ago77% |
Momentum ODDS (%) | 1 day ago77% |
MACD ODDS (%) | 1 day ago79% |
TrendWeek ODDS (%) | 1 day ago69% |
TrendMonth ODDS (%) | 1 day ago68% |
Advances ODDS (%) | 8 days ago68% |
Declines ODDS (%) | N/A |
BollingerBands ODDS (%) | 1 day ago70% |
Aroon ODDS (%) | 1 day ago67% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EWI | 48.14 | 0.28 | +0.59% |
iShares MSCI Italy ETF | |||
REVS | 26.28 | 0.10 | +0.36% |
Columbia Research Enhanced Value ETF | |||
SYFI | 35.95 | 0.08 | +0.23% |
AB Short Duration High Yield ETF | |||
JMEE | 59.21 | -0.02 | -0.03% |
JPMorgan Small & Mid Cap Enh Eq ETF | |||
PBE | 64.10 | -0.28 | -0.43% |
Invesco Biotechnology & Genome ETF |
A.I.dvisor indicates that over the last year, DMCY has been closely correlated with STM. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if DMCY jumps, then STM could also see price increases.
Ticker / NAME | Correlation To DMCY | 1D Price Change % | ||
---|---|---|---|---|
DMCY | 100% | +1.83% | ||
STM - DMCY | 79% Closely correlated | +1.03% | ||
RIO - DMCY | 70% Closely correlated | -0.43% | ||
STLA - DMCY | 60% Loosely correlated | -1.57% | ||
BAM - DMCY | 56% Loosely correlated | +0.29% | ||
WDS - DMCY | 55% Loosely correlated | +0.06% | ||
More |